Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEORAL for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where NEORAL was used for Pustular psoriasis.

Most Reported Side Effects for NEORAL

Side Effect Reports % Deaths Hosp.
Blood creatinine increased 18 7.0% 2 7
Death 17 6.6% 17 1
Immunosuppressant drug level increased 14 5.4% 3 7
Renal failure 13 5.0% 3 7
Interstitial lung disease 11 4.3% 6 3
Kidney transplant rejection 11 4.3% 3 7
Renal impairment 11 4.3% 1 3
Maternal exposure during pregnancy 10 3.9% 0 3
Oral administration complication 9 3.5% 4 4
Pyrexia 9 3.5% 2 5
Renal failure acute 9 3.5% 0 8
Drug interaction 8 3.1% 1 6
Dyspnoea 8 3.1% 4 7
Oedema 8 3.1% 2 3
Oedema peripheral 8 3.1% 1 8

Other Indications for NEORAL

Renal transplant (52) Off label use (22) Interstitial lung disease (18) Prophylaxis against transplant rejection (14) Product used for unknown indication (13) Immunosuppression (12) Nephrotic syndrome (10) Aplastic anaemia (8) Heart transplant (8) Liver transplant (8)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) SECUKINUMAB (317) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) EFALIZUMAB (101)

Related Pages

NEORAL Full Profile All Pustular psoriasis Drugs NEORAL Demographics NEORAL Timeline